Takeover

Acquirers

Mallinckrodt plc

Targets
3
Filings
3
Median premium
50%
First filing
Nov 9, 2017
Latest filing
May 12, 2025

Targets

CompanyScore before dealScore nowFilingsLatest
Endo LP1 / 7—1May 12, 2025
Sucampo Pharmaceuticals, Inc.——1Jan 16, 2018
Ocera Therapeutics, Inc.——1Nov 9, 2017

Deal filings

FiledCompanyFormPricePremium
May 12, 2025Endo LPDEFM14A$113.1949.9%
Jan 16, 2018Sucampo Pharmaceuticals, Inc.SC TO-T——
Nov 9, 2017Ocera Therapeutics, Inc.SC TO-T——